These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20656210)

  • 1. Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer.
    Mohile SG; Lacy M; Rodin M; Bylow K; Dale W; Meager MR; Stadler WM
    Crit Rev Oncol Hematol; 2010 Aug; 75(2):152-9. PubMed ID: 20656210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.
    Alibhai SM; Timilshina N; Duff-Canning S; Breunis H; Tannock IF; Naglie G; Fleshner NE; Krahn MD; Warde P; Marzouk S; Tomlinson GA
    Cancer; 2017 Jan; 123(2):237-244. PubMed ID: 27583806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive problems in patients on androgen deprivation therapy: a qualitative pilot study.
    Wu LM; Diefenbach MA; Gordon WA; Cantor JB; Cherrier MM
    Urol Oncol; 2013 Nov; 31(8):1533-8. PubMed ID: 22975107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
    McGinty HL; Phillips KM; Jim HS; Cessna JM; Asvat Y; Cases MG; Small BJ; Jacobsen PB
    Support Care Cancer; 2014 Aug; 22(8):2271-80. PubMed ID: 24859915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Androgen Deprivation Therapy on Self-Reported Cognitive Function in Men with Prostate Cancer.
    Marzouk S; Naglie G; Tomlinson G; Duff Canning S; Breunis H; Timilshina N; Alibhai SMH
    J Urol; 2018 Aug; 200(2):327-334. PubMed ID: 29477720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
    Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
    Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
    Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
    Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer.
    Kluger J; Roy A; Chao HH
    Curr Oncol Rep; 2020 Feb; 22(3):24. PubMed ID: 32048059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive effects of hormone therapy in men with prostate cancer: a review.
    Nelson CJ; Lee JS; Gamboa MC; Roth AJ
    Cancer; 2008 Sep; 113(5):1097-106. PubMed ID: 18666210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized cognitive training in prostate cancer patients on androgen deprivation therapy: a pilot study.
    Wu LM; Amidi A; Tanenbaum ML; Winkel G; Gordon WA; Hall SJ; Bovbjerg K; Diefenbach MA
    Support Care Cancer; 2018 Jun; 26(6):1917-1926. PubMed ID: 29282534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer.
    Alibhai SM; Breunis H; Timilshina N; Marzouk S; Stewart D; Tannock I; Naglie G; Tomlinson G; Fleshner N; Krahn M; Warde P; Canning SD
    J Clin Oncol; 2010 Dec; 28(34):5030-7. PubMed ID: 21041708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol and cognition during androgen deprivation in men with prostate carcinoma.
    Salminen EK; Portin RI; Koskinen AI; Helenius HY; Nurmi MJ
    Cancer; 2005 Apr; 103(7):1381-7. PubMed ID: 15717315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer.
    Gunlusoy B; Ceylan Y; Koskderelioglu A; Gedizlioglu M; Degirmenci T; Ortan P; Kozacioglu Z
    Urology; 2017 May; 103():167-172. PubMed ID: 28188757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of event-based prospective memory and time-based prospective memory in patients with prostate cancer receiving androgen-deprivation therapy: a neuropsychological study.
    Yang J; Zhong F; Qiu J; Cheng H; Wang K
    Eur J Cancer Care (Engl); 2015 Mar; 24(2):198-204. PubMed ID: 25711542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical function in men with prostate cancer on androgen deprivation therapy.
    Clay CA; Perera S; Wagner JM; Miller ME; Nelson JB; Greenspan SL
    Phys Ther; 2007 Oct; 87(10):1325-33. PubMed ID: 17684084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
    Cherrier MM; Rose AL; Higano C
    J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.
    Sun M; Cole AP; Hanna N; Mucci LA; Berry DL; Basaria S; Ahern DK; Kibel AS; Choueiri TK; Trinh QD
    J Urol; 2018 Jun; 199(6):1417-1425. PubMed ID: 29410294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model.
    Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ
    Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen deprivation and cognition in prostate cancer.
    Salminen E; Portin R; Korpela J; Backman H; Parvinen LM; Helenius H; Nurmi M
    Br J Cancer; 2003 Sep; 89(6):971-6. PubMed ID: 12966411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
    Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
    Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.